80 related articles for article (PubMed ID: 22740080)
1. Hesperidin inhibits cyclophosphamide-induced tumor growth delay in mice.
Hosseinimehr SJ; Jalayer Z; Naghshvar F; Mahmoudzadeh A
Integr Cancer Ther; 2012 Sep; 11(3):251-6. PubMed ID: 22740080
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomide.
Ding Q; Kestell P; Baguley BC; Palmer BD; Paxton JW; Muller G; Ching LM
Cancer Chemother Pharmacol; 2002 Sep; 50(3):186-92. PubMed ID: 12203100
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
Teicher BA; Holden SA; Goff DA; Wright JE; Tretyakov O; Ayash LJ
Cancer Chemother Pharmacol; 1996; 38(6):553-60. PubMed ID: 8823498
[TBL] [Abstract][Full Text] [Related]
4. Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.
Futami H; Jansen R; MacPhee MJ; Keller J; McCormick K; Longo DL; Oppenheim JJ; Ruscetti FW; Wiltrout RH
J Immunol; 1990 Dec; 145(12):4121-30. PubMed ID: 2258610
[TBL] [Abstract][Full Text] [Related]
5. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
6. Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine.
Lakshmi C; Deb C; Ray C; Ray MR
Neoplasma; 2005; 52(1):68-73. PubMed ID: 15739030
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immunostimulant activity and chemoprotective effect of mangrove Rhizophora apiculata against cyclophosphamide induced toxicity in BALB/c mice.
Vinod Prabhu V; Guruvayoorappan C
Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):608-15. PubMed ID: 22211366
[TBL] [Abstract][Full Text] [Related]
8. Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.
Pawlik TM; Nakamura H; Mullen JT; Kasuya H; Yoon SS; Chandrasekhar S; Chiocca EA; Tanabe KK
Cancer; 2002 Sep; 95(5):1171-81. PubMed ID: 12209705
[TBL] [Abstract][Full Text] [Related]
9. Chemoprotective effects of hesperidin against genotoxicity induced by cyclophosphamide in mice bone marrow cells.
Ahmadi A; Hosseinimehr SJ; Naghshvar F; Hajir E; Ghahremani M
Arch Pharm Res; 2008 Jun; 31(6):794-7. PubMed ID: 18563363
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide-using nonmyeloablative allogeneic cell therapy against renal cancer with a reduced risk of graft-versus-host disease.
Eto M; Harano M; Tatsugami K; Harada M; Kamiryo Y; Kiyoshima K; Hamaguchi M; Tsuneyoshi M; Yoshikai Y; Naito S
Clin Cancer Res; 2007 Feb; 13(3):1029-35. PubMed ID: 17289899
[TBL] [Abstract][Full Text] [Related]
11. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
12. [Changes and significance of peripheral blood platelet count in tumor shrinkage induced by a low dose of CTX in T739 mice].
Li ML; Jia YJ; Jiang MN; Shu XH; Li CG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):567-9. PubMed ID: 18538085
[TBL] [Abstract][Full Text] [Related]
13. A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice.
Malvicini M; Rizzo M; Alaniz L; Piñero F; García M; Atorrasagasti C; Aquino JB; Rozados V; Scharovsky OG; Matar P; Mazzolini G
Clin Cancer Res; 2009 Dec; 15(23):7256-65. PubMed ID: 19920110
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of triterpenoid fractions from the rhizomes of Astilbe chinensis on cyclophosphamide-induced toxicity in tumor-bearing mice.
Sun HX; Peng XY
J Ethnopharmacol; 2008 Sep; 119(2):312-7. PubMed ID: 18692125
[TBL] [Abstract][Full Text] [Related]
15. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant Ganoderma lucidum immunoregulatory protein on cyclophosphamide-induced leukopenia in mice.
Zhou H; Sun F; Li H; Zhang S; Liu Z; Pei J; Liang C
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):426-33. PubMed ID: 23656432
[TBL] [Abstract][Full Text] [Related]
17. Importance of signaling via the IFN-alpha/beta receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor.
Mokyr MB; Place AT; Artwohl JE; Valli VE
Cancer Immunol Immunother; 2006 Apr; 55(4):459-68. PubMed ID: 15965646
[TBL] [Abstract][Full Text] [Related]
18. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate.
Chakraborty P; Sk UH; Bhattacharya S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):971-80. PubMed ID: 19221751
[TBL] [Abstract][Full Text] [Related]
19. Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice.
Wang J; Tong X; Li P; Cao H; Su W
J Ethnopharmacol; 2012 Feb; 139(3):788-95. PubMed ID: 22212503
[TBL] [Abstract][Full Text] [Related]
20. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]